For fit patients with CLL, frontline venetoclax-ibrutinib improves survival.

Published Date: 15 Dec 2023

FCR is not as good as the time-limited method based on MRD response, but U. s. applicability not entirely clear?

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Accuracy of Skin Cancer Diagnosis Varies by Physician, Exam Method

2.

SBRT May Beat Brachytherapy in Prostate Cancer

3.

DBT Reduced Suicide Attempts in Adolescents with Bipolar Disorder.

4.

Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation

5.

Ultrasound imaging of breast cancer tumors offers noninvasive monitoring of treatment effectiveness


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot